CLDN1 and Alzheimer disease: Furthermore, in the presence of RAP, AMP-IBP5 failed to increase the epidermal expression of claudin-1 (Figure 8C) or enhance skin barrier function, as evaluated by a permeability assay (Figure 8D), in AD mice.